EQL PHARMA AB revenue breakdown overview

EQL PHARMA AB revenue for the last year amounted to 373.50 M SEK, the most of which — 373.52 M SEK — came from its highest performing source at the moment, Medicines, the year earlier bringing 264.17 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought EQL PHARMA AB 164.83 M SEK, and the year before that — 145.28 M SEK.